Peptide therapy, made
accountable.

Peptide therapy has lived inside boutique longevity clinics and concierge memberships — priced out of reach for the people who'd benefit most. Meto brings the same clinical rigor, priced without the markup, and proves itself with outcome data instead of claims.

Two people holding hands in conversation

Peptides aren't new.
Access is.

  • The problem

    Decades of research, silo'd into
    $10K/year memberships.

    GLP-1s, BPC-157, thymosin, NAD+ — these molecules have been studied for decades, and clinicians in concierge medicine have prescribed them for years. But for everyone else? Research-chemical websites, sketchy sourcing, or a waiting list at a boutique clinic that charges more per year than most people make in a month.

  • What we're doing

    Medical-grade peptide care, without
    the concierge tag.

    We took everything that works about boutique peptide clinics — real clinician oversight, FDA-registered compounding, transparent dosing — and stripped out what doesn't: the gatekeeping, the inflated pricing, the 'membership' theatre. Same standard of care. A fraction of the cost.

A regulatory window.
And a moat built on
outcomes.

HHS reclassified ~14 peptides back to compounding-eligible status in early 2026. The FDA advisory committee meets in July. Millions of people currently buying research-grade peptides from overseas suppliers will want to do it properly. We're building the infrastructure to serve them — and the outcomes dataset that keeps Meto ahead once they arrive.

Lab-driven, not trend-driven

Your protocol is matched to your labs — IGF-1, hs-CRP, HbA1c — not whatever a biohacker is posting about this week.

Personalized over packaged

Your goals, your labs, your protocol. Compounded to your dose, not whatever the manufacturer decided to bottle.

Outcome-tracked, not outcome-claimed

Weekly symptom logs, repeat labs at 3 and 6 months. If the protocol isn't working, the data tells us first.

Affordable over exclusive

Cash pricing, HSA/FSA eligible. No application, no waitlist, no concierge markup.

50
States covered by our clinician network
2,400+
active members on Meto protocols
< 24h
typical care-team response time
4.9 / 5
member satisfaction score
Woman with her face raised to the sun

Four non-
negotiables

We won't ship anything we wouldn't take ourselves. Every peptide is compounded by an FDA-registered pharmacy, batch-tested by an independent lab, and prescribed only after a clinician has read your file.

Board-certified clinicians

MDs and nurse practitioners trained in obesity medicine, internal medicine, and metabolic health. The same clinician every visit.

FDA-registered pharmacies

503A compounding pharmacies — the facilities that supply US hospitals. Never research-grade, never grey-market.

Lab-verified purity

Every batch tested by an independent third-party lab. Certificates of Analysis available to members on request.

Transparent cash pricing

No markups, no membership traps. HSA/FSA eligible. See exactly what each protocol costs before you start.

Peptide therapy, for the
rest of us

Every Meto protocol starts with a $149 lab panel. A clinician reviews your results within 24 hours and proposes the protocol — or tells you it isn't a fit. No application, no waitlist.